Unibioscreen Secures Further Development of its Two Lead Compounds Into Clinical Phases
Brussels, Belgium (ots/PRNewswire) - Unibioscreen S.A., the Brussels specialist oncology company, is pleased to announce that it has succeeded in the closing of a new financing round of EUR 5 million from existing shareholders (ING, Société Générale Asset Management, E-capital, Brustart, UFG-Group and business angels) and from Hunza Ventures. This round brings ...
plus